Newborn Screening Saves Lives Reauthorization Act of 2021

Bill: 117-hr-482
Sponsor: Rep. Roybal-Allard, Lucille [D-CA-40]
Introduced: 2021-01-25 in the House
Policy area: Health
Subjects: Child health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Genetics
Government studies and investigations
Health information and medical records
Health promotion and preventive care
Health technology, devices, supplies
Medical ethics
Medical research
Medical tests and diagnostic methods
State and local government operations

Summary:
action_date: 2021-01-25
text: 

Newborn Screening Saves Lives Reauthorization Act of 2021

 
This bill reauthorizes through FY2026 and revises several programs and activities relating to newborn screening for certain conditions and genetic, endocrine, and metabolic diseases.
 
Among its changes, the bill reauthorizes and makes mandatory
 
 
the Hunter Kelly Research Program at the National Institutes of Health, and
 
national surveillance activities conducted by the Centers for Disease Control and Prevention.
 
 
The bill also aligns statutory requirements for research on non-identified newborn blood spots with federal regulations governing research on human subjects. These blood spots are collected as part of newborn screening programs, and some states make them available for biomedical and public health research. Under current regulations, research on non-identified bio-specimens such as blood spots is not considered to be research on human subjects, to which additional protections apply.

action_date: 2021-06-23
text: 

Newborn Screening Saves Lives Reauthorization Act of 2021

 
This bill reauthorizes through FY2026 and revises several programs and activities relating to newborn screening for certain conditions and genetic, endocrine, and metabolic diseases.
 
Among its changes, the bill reauthorizes and makes mandatory
 
 
the Hunter Kelly Research Program at the National Institutes of Health, and
 
national surveillance activities conducted by the Centers for Disease Control and Prevention.
 
 
The bill also aligns statutory requirements for research on non-identified newborn blood spots with federal regulations governing research on human subjects. These blood spots are collected as part of newborn screening programs, and some states make them available for biomedical and public health research. Under current regulations, research on non-identified bio-specimens such as blood spots is not considered to be research on human subjects, to which additional protections apply.


Legislative actions:
action_date: 2021-06-24
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-06-23
text: Pursuant to section 11 of H. Res. 486, and the motion offered by Mr. McGovern, the following bills passed under suspension of the rules: H.R. 482; H.R. 704; H.R. 961, as amended; H.R. 1314; H.R. 2571, as amended; H.R. 2679, as amended; H.R. 2694; H.R. 2922, as amended; H.R. 3182; H.R. 3239; H.R. 3241, as amended; H.R. 3723; H.R. 3752; H.R. 3841; S. 409; and S. 1340. (consideration: CR H3026-3052; text: CR H3026-3027)
action_date: 2021-06-23
text: Passed/agreed to in House: Pursuant to section 11 of H. Res. 486, and the motion offered by Mr. McGovern, the following bills passed under suspension of the rules: H.R. 482; H.R. 704; H.R. 961, as amended; H.R. 1314; H.R. 2571, as amended; H.R. 2679, as amended; H.R. 2694; H.R. 2922, as amended; H.R. 3182; H.R. 3239; H.R. 3241, as amended; H.R. 3723; H.R. 3752; H.R. 3841; S. 409; and S. 1340.(consideration: CR H3026-3052; text: CR H3026-3027)
action_date: 2021-06-23
text: Pursuant to the provisions of H. Res. 486, proceedings on H.R. 482 are considered vacated.
action_date: 2021-06-22
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2021-06-22
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 482.
action_date: 2021-06-22
text: Considered under suspension of the rules. (consideration: CR H2940-2942; text: CR H2940-2941)
action_date: 2021-06-22
text: Mr. Pallone moved to suspend the rules and pass the bill.
action_date: 2021-02-02
text: Referred to the Subcommittee on Health.
action_date: 2021-01-25
text: Referred to the House Committee on Energy and Commerce.
action_date: 2021-01-25
text: Introduced in House
action_date: 2021-01-25
text: Introduced in House